Austrian Forum Against Cancer
Quick facts
Phase 2 pipeline
- bendamustine plus bortezomib plus dexamethasone
- Dexamethasone, Bortezomib, Doxorubicin
- lenalidomide plus dexamethasone
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:
Related
- Sector hub: All tracked pharma companies